• OFID 2018:5 (Suppl 1) • Poster Abstracts non-groupable 7.9% and non-capsulated 44.7%. Clonal complex was determined for 58 isolates. Independent predictor of Nm carriage: attendance at night clubs (adjusted OR: 3.38,; P = 0.013); passive smoking at home (adjusted OR: 0.55, P = 0.025). Preliminary data show a total of 10 different clonal complexes present among all serogroups in the 1-9 years group aged and 13 in 10-17 years.
Background. There is controversy about the appropriate management of acute osteomyelitis in children.
Methods. Retrospective cohort study of presentation, management and outcomes of all patients admitted with acute osteomyelitis (<2 weeks duration) during 2010-2016 at 4 US and Canadian tertiary care hospitals (hosp). Long-term complications (LTC) were defined as amputation, limp, chronic or secondary infection, or readmission. Overall complications included LTC, admission to ICU and delayed surgery (>72 hours).
Results. 712 patients were admitted, with a median age of 8.0 years. There were significant differences in rates of initial use of MRI for diagnosis, MRSA, PICC insertion, hosp stay and IV antibiotic duration (Table 1) . Clindamycin (45.7%), cefazolin (24.1%) and vancomycin (13.7%) were the most common IV antibiotics used while clindamycin (47.1%) and cephalexin (38.6%) predominated for oral. The median age of patients with MRSA was similar to those without MRSA (8.2 vs. 7.8 years, P = 0.18), but MSSA patients were older (9.6 vs. 6.9 years, P < 0.0001). Contiguous septic arthritis was more common in younger children (6.8 vs. 8.5 years, P < 0.001). MRSA patients had higher overall complication rates (25.2% vs. 10.0%, P < 0.0001), but long-term complications were unrelated to duration of IV or total antibiotics. Conclusion. Despite significant variation in management, long-term complication rates were similar across US and Canadian sites with different MRSA rates. These data support equivalence of shorter (≤ 4 days) duration of IV antibiotics and reduced need for PICC insertion for pediatric osteomyelitis.
Disclosures. All authors: No reported disclosures. Methods. In a retrospective case-control study children aged 1 month to 18 years seen at Texas Children's Hospital from 2010 to 2017 with NTS MSK infections were compared with patients with SA MSK infections. Date of infection matched controls were selected 3:1. Patients with known hemoglobinopathies, immunodeficiencies or infections due to penetrating trauma or related to prosthetic devices were excluded. Logistic regression was used to evaluate associations between historical, clinical and laboratory variables and NTS or SA MSK infection.
Comparison of Musculoskeletal Infections Due to Non-Typhoidal Salmonella Species and Staphylococcus aureus in Immunocompetent Children
Results. From 2010 to 2017, 27 cases of NST MSK infections were identified, 12 of which occurred in healthy children. The control group had 37 patients. The case and control groups had similar baseline demographics. Predictors of NTS MSK infection included exposure to reptiles (odds ratio [OR], 6.86; 95% confidence interval [CI], 1.03-45.60) and a history of preceding diarrhea (OR, 7.25; 95% CI, . No presenting signs or laboratory markers were identified as predictors of NTS MSK infection. Blood cultures were positive in 8 (66.7%) of the NTS MSK cases. Length of hospital stay, duration of fever or complications did not differ significantly between the two groups and children with NTS MSK infections had a low rate of complications (16.7%). Six (50%) patients with NTS infections had unremarkable evaluations for hemoglobinopathies and immunodeficiencies.
Conclusion. Healthy children with NTS MSK infections often report a history of reptile exposure and preceding diarrhea compared with children with MSK infections due to SA. If such history is obtained, addition of a third-generation cephalosporin to empirically cover for NST should be considered pending blood and tissue cultures. In contrast to previous case reports and case series, children with NTS MSK infections had a lower rate of complications.
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